Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy

Health Policy

Volumn 105, Issue 2-3, 2012, Pages 176-184

  Henschke, Cornelia ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Assistive technology devices; Duchenne muscular dystrophy; Financing; Germany; Qualitative study

Indexed keywords

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASSISTIVE TECHNOLOGY DEVICE; CHILD; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DEVICE APPROVAL; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GERMANY; GOVERNMENT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MALE; MEDICAL INFORMATION; PRESCHOOL CHILD; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CHILD; CHILD, PRESCHOOL; FEMALE; FINANCING, GOVERNMENT; GERMANY; GOVERNMENT REGULATION; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; SELF-HELP DEVICES; YOUNG ADULT;

EID: 84859762771     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2012.01.013     Document Type: Article

References (36)

1. Bamer A.M., Connell F.A., Dudgeon B.J., Johnson K.L. Frequency of purchase and associated costs of assistive technology for Washington State Medicaid program enrollees with spina bifida by age. Disability and Health Journal 2010, 3:155-161.
2. Okoro C.A., Strine T.W., Balluz L.S., Crews J.E., Mokdad A.H. Prevalence and correlates of depressive symptoms among United States adults with disabilities using assistive technology. Preventive Medicine 2010, 50:204-209.
3. Cincotti F., Mattia D., Aloise F., Bufalari S., Schalk G., Oriolo G., et al. Non-invasive brain-computer interface system: towards its application as assistive technology. Brain Research Bulletin 2008, 75:796-803.
4. Cronin S., Hardiman O., Traynor B.J. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007, 68(13):1002-1007.
5. Logroscino G., Traynor B.J., Hardiman O., Chiò A., Mitchell D., Swingler R.J., et al. Incidence of amyotrophic lateral sclerosis in Europe. Journal of Neurology, Neurosurgery and Psychiatry 2010, 10.1136/jnnp.2009.183525.
6. Bushby K., Bourkeb J., Bullockc R., Eaglea M., Gibsond M., Quinbyd J. The multidisciplinary management of Duchenne muscular dystrophy. Current Paediatrics 2005, 15:292-300.
7. Kirschner J., Schessl J., Schara U., Reitter B., Stettner G.M., Hobbiebrunken E., et al. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial. The Lancet Neurology 2010, 9(11):1053-1059.
8. Bushby K., Finkel R., Birnkrant D.J., Case L.E., Clemens P.R., Cripe L., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology 2010, 9(1):77-93.
9. Simmons Z. Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. The Neurologist 2005, 11(5):257-270.
10. Manzur A.Y., Francesco M. The management of Duchenne muscular dystrophy. Current Paediatrics 2002, I2:261-268.
11. Gesundheitsberichterstattung des Bundes Das Informationssystem der Gesundheitsberichterstattung des Bundes 2011, http://www.gbe-bund.de/.
12. Schreyögg J., Bäumler M., Busse R. Balancing adoption and affordability of medical devices in Europe. Health Policy 2009, 92:218-224.
13. Phukan J., Hardiman O. The management of amytrophic lateral sclerosis. Journal of Neurology 2009, 256:176-186.
14. Federal Ministry of Health Daten des Gesundheitswesens 2010, http://www.bundesgesundheitsministerium.de/fileadmin/redaktion/pdf_publikationen/Daten_des_Gesundheitswesens.pdf.
15. Busse R., Stargardt T., Schreyögg J. Determining the health benefit basket of the statutory health insurance scheme in Germany: methodologies and criteria. European Journal of Health Economics 2005, 6(Suppl. 1):30-36.
16. Busse R., Riesberg A. Health care systems in transition: Germany 2004, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen.
17. Denzin N.K., Lincoln J.S. The SAGE handbook of qualitative research 2005, SAGE Publications, Thousands Oaks.
18. Hsieh H.-F., Shannon S.E. Three approaches to qualitative content analysis. Qualitative Health Research 2005, 15(9):1277-1288.
19. Miles M.B., Huberman A.M. Qualitative data analysis 1994, SAGE Publications, Thousand Oaks.
20. Mayring P. Qualitative Inhaltsanalyse-Grundlagen und Techniken 2008, Beltz Verlag, Weinheim und Basel. 10th ed.
21. Schilling J. On the pragmatics of qualitative assessment. European Journal of Psychological Assessment 2006, 22(1):28-37.
22. Eagle M., Baudouin S.V., Chandler C., Giddings D.R., Bullock R., Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscular Disorders 2002, 12(10):926-929.
23. Gomez-Merino E., Bach J.R. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. American Journal of Physical Medicine and Rehabilitation 2002, 81(6):411-415.
24. Hyde S.A., FlŁytrup I., Glent S., Kroksmark A.K., Salling B., Steffensen B.F., et al. A randomized comparative study of two methods for controlling tendo Achilles contracture in Duchenne muscular dystrophy. Neuromuscular Disorders 2000, 10(4-5):257-263.
25. Bakker J.P., de Groot I.J., Beckerman H., de Jong B.A., Lankhorst G.J. The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature. Clinical Rehabilitation 2000, 4(4):343-359.
26. Deutsche Vereinigung für Rehabilitation Lösungsoptionen der Deutschen Vereinigung für Rehabilitation zur überwindung von Problemen bei der Versorgung von Hilfsmitteln. Die Rehabilitation 2010, 49(Suppl. 1):S5-S36.
27. Kersbergen A.L. Case management: a rich history of coordinating care to control cost. Nursing Outlook 1996, 44(4):169-172.
28. Brault G.L., Kissinger L.D. Case management: ambiguous at EST. Journal of Pediatric Health Care 1991, 5(4):179-183.
29. Chan S., Mackenzie A., Jacobs P. Cost-effectiveness analysis of case management versus routine community care organization for patients with chronic schizophrenia. Archives of Psychiatric Nursing 2000, XIV(2):98-104.
30. Norris S.L., Nicholas P.J., Caspersen C.J., Glasgow R.E., Engelgau M.M., Jack L., et al. The effectiveness of disease and case management for people with diabetes: a systematic review. American Journal of Preventive Medicine 2002, 22(4S):15-38.
31. Shumway M., Boccellari A., O'Brien K., Okin R.L. Cost-effectiveness of clinical case management for ED frequent users: results of a randomized trial. American Journal of Emergency Medicine 2008, 26(2):155-164.
32. Gilmer T.P., Roze S., Valentine W.J., Emy-Albrecht K., Ray J.A., Cobden D., et al. Cost-effectiveness of diabetes case management for low-income populations. Health Services Research 2007, 42(5):1943-1959.
33. Holloway F., Oliver N., Collins E., Carson J. Case management: a critical review of the outcome literature. European Psychiatry 1995, 10(3):113-128.
34. Eichler H-G., Sheldon S.X., Gerth W.C., Mavros P., Jönsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?. Value in Health 2004, 7(5):518-528.
35. Holloway F., Carson J. Case management: an update. International Journal of Social Psychiatry 2001, 47(3):21-31.
36. Girard N. The case management: model of patient care delivery. AORN Journal 1994, 60(3):403-415.